Breakthrough Therapy Designation

Zogenix gains Breakthrough status, but GW Pharma still ahead in Dravet syndrome

https://pharmaphorum.com/news/zogenix-gains-breakthrough-status-but-gw-pharma-still-ahead-in-dravet-syndrome/

Novartis adds Promacta to breakthrough status roll-call

https://pharmaphorum.com/top-pharmaceutical-companies/novartis/fda-grants-novartis-drug-breakthrough-status-first-line-anaemia/

Breakthrough status for nephropathy drug lifts Omeros

https://pharmaphorum.com/news/breakthrough-designation-nephropathy-drug-lifts-omeros/

Enzyvant gains double fast-track for rare disease drug

https://pharmaphorum.com/news/enzyvant-gains-double-fast-track-rare-disease-drug/

Rebiotix microbiome drug success against C diff infection

https://pharmaphorum.com/news/rebiotix-microbiome-drug-success-c-diff-infection/

New breakthrough designations for Roche’s Alecensa and Actemra

https://pharmaphorum.com/news/roches-alecensa-gets-faster-us-review/

Janssen’s depression drug gains second breakthrough status

https://pharmaphorum.com/news/janssens-depression-drug-gains-second-breakthrough-status/

New Breakthrough status for Darzalex in earlier myeloma treatment

https://pharmaphorum.com/news/new-breakthrough-status-darzalex-earlier-myeloma-treatment/

Close in 10 seconds

Pharmaphorum.com

Search